- Home
- WMK vs HRMY Comparison
WMK vs HRMY Comparison
Compare WMK & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WMK
- HRMY
- Stock Information
- Founded
- WMK 1912
- HRMY 2017
- Country
- WMK United States
- HRMY United States
- Employees
- WMK N/A
- HRMY N/A
- Industry
- WMK Food Chains
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- WMK Consumer Staples
- HRMY Health Care
- Exchange
- WMK Nasdaq
- HRMY Nasdaq
- Market Cap
- WMK 1.8B
- HRMY 1.5B
- IPO Year
- WMK N/A
- HRMY 2020
- Fundamental
- Price
- WMK $65.92
- HRMY $29.50
- Analyst Decision
- WMK
- HRMY Strong Buy
- Analyst Count
- WMK 0
- HRMY 10
- Target Price
- WMK N/A
- HRMY $50.80
- AVG Volume (30 Days)
- WMK 120.6K
- HRMY 870.4K
- Earning Date
- WMK 11-06-2025
- HRMY 11-04-2025
- Dividend Yield
- WMK 2.06%
- HRMY N/A
- EPS Growth
- WMK 15.99
- HRMY 58.41
- EPS
- WMK 4.02
- HRMY 3.10
- Revenue
- WMK $4,842,632,000.00
- HRMY $772,527,000.00
- Revenue This Year
- WMK N/A
- HRMY $20.10
- Revenue Next Year
- WMK N/A
- HRMY $16.50
- P/E Ratio
- WMK $16.40
- HRMY $9.57
- Revenue Growth
- WMK 1.75
- HRMY 17.74
- 52 Week Low
- WMK $62.25
- HRMY $25.52
- 52 Week High
- WMK $90.23
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- WMK 33.58
- HRMY 55.32
- Support Level
- WMK $65.46
- HRMY $29.46
- Resistance Level
- WMK $68.80
- HRMY $30.96
- Average True Range (ATR)
- WMK 1.48
- HRMY 0.82
- MACD
- WMK -0.25
- HRMY 0.70
- Stochastic Oscillator
- WMK 8.52
- HRMY 73.16
About WMK Weis Markets Inc.
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The center-store goods and fresh goods jointly account for the majority of the company's total revenue.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.